Investors with the goal of beating the broader market often turn to stock selection. Strategic choices in individual stocks can have a profound impact on your wealth.
The closing price of Heron Therapeutics Inc (NASDAQ: HRTX) was $2.05 for the day, down -2.84% from the previous closing price of $2.11. In other words, the price has decreased by -$2.84 from its previous closing price. On the day, 2.7 million shares were traded.
Ratios:
Our analysis of HRTX’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 1.76 and its Current Ratio is at 2.40.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Rodman & Renshaw on June 13, 2024, initiated with a Buy rating and assigned the stock a target price of $7.
On April 23, 2024, CapitalOne started tracking the stock assigning a Overweight rating and target price of $6.
Needham reiterated its Buy rating for the stock on March 13, 2024, while the target price for the stock was revised from $4 to $5.
Valuation Measures:
For the stock, the TTM Price-to-Sale (P/S) ratio is 2.11.
Stock Price History:
Over the past 52 weeks, HRTX has reached a high of $3.93, while it has fallen to a 52-week low of $1.04. The 50-Day Moving Average of the stock is -7.35%, while the 200-Day Moving Average is calculated to be 7.83%.
Shares Statistics:
A total of 152.43M shares are outstanding, with a floating share count of 151.09M. Insiders hold about 0.97% of the company’s shares, while institutions hold 78.67% stake in the company.
